Literature DB >> 17320748

Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria.

Courtney J Jolliffe1, Ian Janssen.   

Abstract

OBJECTIVES: The study objectives were to develop age-specific adolescent metabolic syndrome (MetS) criteria that were linked to the health-based Adult Treatment Panel III (ATP) and International Diabetes Federation (IDF) adult criteria.
BACKGROUND: There has been no consistency in the criteria used to diagnose the MetS in adolescents. Studies have either applied adult criteria or arbitrarily chosen adolescent high-risk cut-points.
METHODS: The adolescent (12 to 19 years old) MetS criteria developed in this study were linked to the ATP and IDF adult criteria with LMS growth curve modeling for each MetS component (waist circumference, systolic and diastolic blood pressure, high-density lipoprotein cholesterol, triglycerides, and glucose). Nationally representative data from the National Health and Nutrition Examination Surveys were used to develop the growth curves.
RESULTS: The growth curves for each MetS component passed through the ATP and IDF cut-points at 20 years of age such that adolescent cut-points were linked to the adult values. Age- and gender-specific cut-points for each MetS component were developed that can be used to define high-risk values in 12- to 19-year-olds. The prevalence of MetS in adolescents nearly doubled over the last decade and was 7.6% on the basis of the newly developed ATP adolescent criteria and 9.6% on the basis of the newly developed IDF adolescent criteria.
CONCLUSIONS: These new criteria should provide improved and age-appropriate approaches for diagnosing MetS among adolescents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320748     DOI: 10.1016/j.jacc.2006.08.065

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  76 in total

1.  Geographical variation in the prevalence of obesity and metabolic syndrome among US adolescents.

Authors:  M D DeBoer; S L Filipp; M J Gurka
Journal:  Pediatr Obes       Date:  2018-12-04       Impact factor: 4.000

2.  Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study.

Authors:  Costan G Magnussen; Juha Koskinen; Wei Chen; Russell Thomson; Michael D Schmidt; Sathanur R Srinivasan; Mika Kivimäki; Noora Mattsson; Mika Kähönen; Tomi Laitinen; Leena Taittonen; Tapani Rönnemaa; Jorma S A Viikari; Gerald S Berenson; Markus Juonala; Olli T Raitakari
Journal:  Circulation       Date:  2010-10-04       Impact factor: 29.690

Review 3.  PCOS in adolescence and type 2 diabetes.

Authors:  Anne-Marie Carreau; Jean-Patrice Baillargeon
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

4.  Association of metabolic syndrome with reduced central serotonergic activity.

Authors:  Rocio Herrera-Marquez; Jorge Hernandez-Rodriguez; Julio Medina-Serrano; Alfonso Boyzo-Montes de Oca; Gabriel Manjarrez-Gutierrez
Journal:  Metab Brain Dis       Date:  2010-12-22       Impact factor: 3.584

Review 5.  Physical activity, cardiorespiratory fitness, and the metabolic syndrome in youth.

Authors:  Rebekah M Steele; Soren Brage; Kirsten Corder; Nicholas J Wareham; Ulf Ekelund
Journal:  J Appl Physiol (1985)       Date:  2008-03-27

Review 6.  Cardiovascular and Metabolic Complications - Diagnosis and Management in Obese Children.

Authors:  Naval K Vikram
Journal:  Indian J Pediatr       Date:  2017-12-08       Impact factor: 1.967

7.  Construct validity of a continuous metabolic syndrome score in children.

Authors:  Joey C Eisenmann; Kelly R Laurson; Katrina D DuBose; Bryan K Smith; Joseph E Donnelly
Journal:  Diabetol Metab Syndr       Date:  2010-01-28       Impact factor: 3.320

8.  Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents.

Authors:  Carlos Juárez-López; Miguel Klünder-Klünder; Patricia Medina-Bravo; Adrián Madrigal-Azcárate; Eliezer Mass-Díaz; Samuel Flores-Huerta
Journal:  BMC Public Health       Date:  2010-06-07       Impact factor: 3.295

9.  Evaluation of a child for secondary causes of obesity and comorbidities.

Authors:  Robert E Kramer; Stephen R Daniels
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

10.  Prevalence of metabolic syndrome and obesity in adolescents aged 12 to 19 years: comparison between the United States and Korea.

Authors:  Jinkyung Park; David C Hilmers; Jason A Mendoza; Janice E Stuff; Yan Liu; Theresa A Nicklas
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.